key: cord-0916992-ytvlvix5 authors: Voicu, Sebastian; Brudon, Alexandre; Modestin, Louis; Nitenberg, Kiyoko; Gonde, Antoine; Malissin, Isabelle; Mégarbane, Bruno title: Reversibility of total airway closure and alveolar consolidation in a COVID‐19 patient: A case study date: 2021-07-29 journal: Nurs Crit Care DOI: 10.1111/nicc.12688 sha: d7e829923cbe3b8dc3d91f27a81b3e7f34726940 doc_id: 916992 cord_uid: ytvlvix5 Coronavirus disease 2019 (COVID‐19) may be complicated by life‐threatening pneumonia requiring tracheal intubation, mechanical ventilation and veno‐venous extracorporeal membrane oxygenation (vvECMO). It is not yet clear to what extent and after which delay the most severe cases of COVID‐19 pneumonia are reversible. Here, we present a 39‐year‐old patient who developed a severe COVID‐19‐attributed acute respiratory distress syndrome (ARDS) resulting in complete alveolar consolidation and airway closure for several weeks. His remarkable ventilatory pattern was established using ventilator airway pressure curve analysis and computed tomography imaging. The patient was managed with supportive care, mechanical ventilation and vvECMO. He received dexamethasone and tocilizumab as immunomodulatory drugs. Despite multiple complications, he recovered and was weaned from vvECMO, ventilator and oxygen on days 75, 95 and 99 post‐intubation, respectively. He was discharged from hospital on day 113. This case study strongly supports the remarkable potential for reversibility of ARDS in COVID‐19 patients and discusses the implications for critical care nursing regarding mechanical ventilation and ECMO device management in patients who may become entirely dependent on vvECMO for oxygenation and carbon dioxide elimination. Severe coronavirus 2019 (COVID-19) disease may be responsible for profound hypoxemia requiring intensive care unit (ICU) admission and invasive mechanical ventilation. 1 In the most severe patients, implementation of veno-venous extracorporeal membrane oxygenation (vvECMO) may be required. Interestingly, survival of vvECMO-treated COVID-19 patients was shown to be relatively good. 2 As COVID-19 is still a new clinical entity, reversibility of the most severe pneumonia cases is still under evaluation. It is not clear which patients may have reasonable chances of recovery and whether very prolonged severe alterations in pulmonary function may reverse. In exceptional cases, persistent acute respiratory distress syndrome (ARDS) leads to pulmonary transplantation as the last resort in COVID-19 patients supported by vvECMO. 3, 4 However, pursuing medical management is futile, and at which stage aggressive interventions such as lung transplantation should be undertaken is unknown. This case study critically presents the clinical and radiological features of a COVID-19 patient with life-threatening pneumonia managed with vvECMO that resulted in total alveolar consolidation and airway closure, which progressively improved in the ICU, allowing the final complete recovery of pulmonary function. Specificities of nursing care are analysed because of the almost complete dependence of the patient on vvECMO for oxygenation and carbon dioxide elimination. The patient gave written informed permission to use any clinical information/material relating to his case anonymously in any subsequent verbal or written presentation of the research. Figure 1A ). What is known about this topic • COVID-19 is responsible for life-threatening pneumonia that may require invasive mechanical ventilation. • Veno-venous extracorporeal membrane oxygenation may be life-saving when managing COVID-19-related refractory hypoxemic pneumonia. • Critical caregivers have important specific roles in the management of mechanically ventilated COVID-19 patients. What this paper adds • The extremely severe COVID-19 patient may develop complete alveolar consolidation and airway closure for several weeks. • Oxygenation and carbon dioxide elimination may be entirely dependent on veno-venous extracorporeal membrane oxygenation for weeks in the COVID-19 patient. • In mechanically ventilated COVID-19 patients, plateau pressure should be monitored often as it may change rapidly and require replacement of volume-controlled with pressure-controlled ventilation to avoid barotrauma. • Extremely severe acute respiratory distress syndrome may be remarkably reversible with no persistent functional disability in the COVID-19 patient. On day 9 post-intubation, he presented a spontaneous left tension pneumothorax complicated by cardiac arrest; he was immediately This patient presented with alveolar condensation of the entire lung tissue including complete absence of air bronchogram on imaging, while the lungs did not participate at all in gas exchanges, which were ensured by vvECMO. This case study is an example of extreme ARDS during which the patient is entirely dependent on vvECMO for oxygenation and carbon dioxide elimination, therefore requiring careful management of vvECMO device by caregivers. Special care was taken during physical therapy and nursing care to protect cannulas and F I G U R E 2 Computed tomography scan below the carina showing air bronchogram (short arrows) and some aerated alveoli (long arrows) as well as a fine partially drained pneumothorax (arrowhead) on day 6 of veno-venous extracorporeal membrane oxygenation (vvECMO) (A). On day 15 of vvECMO the computed tomography showed total absence of air in the airways and alveoli (B) and the chest X-ray on the same day showed complete absence of air (C). On day 20 after weaning from vvECMO and weaning from ventilator and oxygen, the chest X-ray showed complete re-aeration of the lungs (D). Embolization of three intercostal arteries and pleural surgery were necessary to stop extensive haemothorax and evacuate the residual haemorrhagic collection. The clinical course of our patient was complicated by left tension pneumothorax requiring emergency drainage. Protecting airways from excessive pressure is a major goal in ARDS patients including in extreme cases like our patient. Interestingly, pneumothorax recurred in our patient despite mechanical ventilation parameters limiting plateau pressures to 29 cmH 2 O as recommended. 5 The pneumothorax occurred when some airways and alveoli were still open (Figure 2A) . The mode of ventilation we used in this paralysed patient was pressure-controlled instead of volume-controlled ventilation, to avoid excessive airway pressure that may lead to barotrauma. During the first days of ICU stay, regular monitoring by nurses while the patient was on volume-controlled ventilation showed that plateau pressures were occasionally above 30 cmH 2 O, requiring a decrease in tidal volume accordingly, to maintain plateau pressures at a maximum of 30 cmH 2 O until the decision was made to switch to pressure-controlled ventilation on day 7. This shows the paramount role of nurses in monitoring mechanical ventilation parameters that highly impact the optimal patient management. The plateau pressure should be monitored as often as possible because pulmonary compliance may deteriorate rapidly in some COVID-19 patients, leading to increased pressures if volume-controlled ventilation is pursued. When plateau pressure increases rapidly, a volume-controlled mode may be replaced by a pressure-controlled mode to protect patent alveoli from barotrauma by controlling the peak pressure. 8 The advantage of this latter mode was to maintain a maximum pressure in the airways of 29 cmH 2 O as the inspiratory pressure level was set at 29 cmH 2 O. However, despite this precautionary measure, pneumothorax recurred, complicated by rapidly resuscitated cardiac arrest. We believe that high levels of PEEP 14 cmH 2 O may have favoured this complication, but the decision to keep a high PEEP was made to prevent alveolar collapse and improve oxygenation. Interestingly, alveolar collapse could not be prevented, and on the recruitment-to-inflation ratio manoeuvre on day 19, compliance decreased to 1.5 mL/cmH 2 O and airways and/or alveoli did not open until ventilation circuit pressure reached 51 cmH 2 O, which was the pressure at which we stopped the insufflation ( Figure 1B) . Such a curve suggesting that air was unable to enter the alveoli may be because of either airway closure or alveolar collapse or condensation. 9 All these phenomena were present in our patient. Previous studies showed that COVID-19 patients had airways closure, a phenomenon that is characterized by closure of all small airways that open only above a threshold pressure, the airway opening pressure. This phenomenon was previously described in ARDS patients 6, 9 and identified by a very low compliance, similar to As shown by computed tomography scan, both total airway closure (proven by total absence of air bronchogram) and total alveolar condensation were present in our patient. It is not possible to establish which of the two was responsible for restricting air entering the lungs. Moreover, a causal relationship between airway closure and alveolar consolidation or vice versa could not be established with certainty. We were able to establish the inflammatory lung pattern on day The extremely low compliance for about 35 days we report in one of the longest vvECMO treatment (71 days) described in COVID-19 survivors demonstrates the spectacular reversibility potential in COVID-19 pneumonia. The case shows also the importance of closely monitoring key ventilation parameters such as plateau pressure and compliance and adapting ventilator settings to the physiologic status of the lung and pursuing optimum care. Prolonged treatment with vvECMO may be associated with survival and complete pulmonary recovery. Informed consent was obtained from the patient for publication. https://orcid.org/0000-0002-2522-2764 Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study Lung transplants for COVID-19-the option of last resort Novel insight from the first lung transplant of a COVID-19 patient Acute respiratory distress syndrome: the Berlin Definition Potential for lung recruitment estimated by the recruitment-to-inflation ratio in acute respiratory distress syndrome: A clinical trial Lung recruitability in COVID-19-associated acute respiratory distress syndrome: a single-center observational study Pressure Controlled Ventilation Airway closure in acute respiratory distress syndrome: an underestimated and misinterpreted phenomenon Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome Reversibility of total airway closure and alveolar consolidation in a COVID-19 patient: A case study